You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 116 No. 1, January 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Suppressor Cell Function in Psoriasis

Daniel N. Sauder, MD; Philip L. Bailin, MD; James Sundeen, MS; Randall S. Krakauer, MD

Arch Dermatol. 1980;116(1):51-55.


Abstract

• Recent studies suggest that autoimmunity may play a role in the pathogenesis of psoriasis. In view of these findings, it is postulated that the immunologic defect may be associated with regulation of the immune system. A study was undertaken to determine whether a suppressor cell defect was present. Two groups of patients with active psoriasis who were receiving no therapy were selected. Peripheral blood lymphocytes were pulsed with concanavalin A, 40 µg/cc, for 48 hours. Their ability to suppress a mixed lymphocyte reaction with both autologous and allogeneic responding cells was assessed. There was a significant decrease in suppressor activity in psoriasis patients compared with normal individuals. Although we have not demonstrated that this mechanism is implicated directly in a causal relationship to psoriasis, it nevertheless gives further support to the possible role of the immune system in the pathogenesis of psoriasis.

(Arch Dermatol 116:51-55, 1980)



Author Affiliations

From the Departments of Dermatology (Drs Sauder and Bailin) and Immunology (Mr Sundeen and Dr Krakauer), The Cleveland Clinic Foundation. Dr Krakauer is a fellow of the Arthritis Foundation. Dr Sauder is now with the Dermatology Branch, National Cancer Institute, Bethesda, Md.


Footnotes

Accepted for publication April 24, 1979.

Preliminary data presented at the Eighth International Congress of the Reticuloendothelial Society, Jerusalem, June 17, 1978.

Reprint requests to Dermatology Branch, National Cancer Institute, Bethesda, MD 20014 (Dr Sauder).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Angiogenic Capability of Peripheral Blood Mononuclear Cells in Psoriasis
Majewski et al.
Arch Dermatol 1985;121:1018-1021.
ABSTRACT  

Increased Helper-Suppressor T-cell Ratio in Psoriasis
Ligresti et al.
Arch Dermatol 1982;118:966-970.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.